Find the investors funding Health Grant rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.

Concert for Cures Series Surpasses $28 Million Raised for Cancer Research Following P!NK’s Electrifying Performance at Petco Park - BioSpace
Curebound is a community-powered cancer research accelerator dedicated to advancing breakthrough science into cures. It focuses on funding high-impact cancer studies and fostering collaborations among scientists, advocates, and philanthropists to improve cancer prevention, detection, and treatment.
Concert for Cures Series Surpasses $28 Million Raised for Cancer Research Following P!NK’s Electrifying Performance at Petco Park BioSpace
| Sep 23, 2026 | Ema | $77.0M | Series B | United States |
| Sep 23, 2026 | Baselayer | $35.0M | Series A | United States |
| Sep 23, 2026 | Hubble Network | $200.0M | Series C | United States |
| Sep 23, 2026 | Topdog | $2.5M | Seed | United States |
You just read who funded Curebound. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.